 |
|
|
|
|
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Aisen P. on PAPER: Cramer PE. et al., 2012, I think this is a very intriguing paper. Most therapeutic programs have targeted amyloid peptide... 15 Feb 2012.
|
|
|
 |
|
|
Aisen P, Jack C, Sperling R. on PAPER: Sperling RA. et al., 2011, It is heartening to see that our recent commentary has sparked a spirited discussion among a... 23 Dec 2011.
|
|
|
|
|
|
Aisen P. on PAPER: Laxton AW. et al., 2010, It is quite interesting that stimulation of the fornix/hypothalamus influences memory, with... 11 Aug 2010.
|
|
|
|
|
|
Aisen P. on PAPER: Hayden KM. et al., 2007, This paper from the Cache County Investigators reports an association between long-term NSAID... 26 Jul 2007.
|
|
|
|
|
|
Aisen P. on NEWS: Safety Concerns Halt ADAPT Trial, Without seeing the data, I cannot comment on the decision to halt
ADAPT. But note that in 2000,... 22 Dec 2004.
|
|
|
|
|
|
Aisen P. on NEWS: Merck Withdraws Vioxx®, What impact does Merck's withdrawal of rofecoxib have on AD patients?
Some AD patients have... 30 Sep 2004.
|
|
|
|
|
|
Aisen P. on NEWS: Trials and Tribulations: Does ADAPT Have to Adapt?, I have read the letter and was quite distressed by it. I am not involved in the ADAPT, though I... 25 Sep 2002.
|
|
|
|
|
|
Aisen P. on LIVE DISCUSSION: From Epidemiology to Therapeutic Trials with Anti-inflammatory Drugs in Alzheimer's Disease: The Role of NSAIDs and Cyclooxygenase on Beta-amyloidosis and Clinical Dementia, The Role of NSAIDs and Cyclooxygenase on Beta-amyloidosis and Clinical... 19 Feb 2002.
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
